Imaging of prehospital stroke therapeutics

References

• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7
   PubMed Web of Science ®Google Scholar
• Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703
   PubMed Web of Science ®Google Scholar
• Jauch EC, Saver JL, Adams HPJr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation 2013;44:870-947
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2014;7:Cd000213
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 2011;123:750-8
   PubMed Web of Science ®Google Scholar
• Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. Jama 2013;309:2480-8
   PubMed Web of Science ®Google Scholar
• The Joint Commission Primary Stroke Center Certification
   Google Scholar
• Schwamm LH, Fonarow GC, Reeves MJ, et al. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2009;119:107-15
   PubMed Web of Science ®Google Scholar
• Schumacher HC, Bateman BT, Boden-Albala B, et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 2007;50:99-107
   PubMed Web of Science ®Google Scholar
• Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med 2010;5:406-9
   PubMed Web of Science ®Google Scholar
• Summers D, Leonard A, Wentworth D, et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke 2009;40:2911-44
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. Jama 2014;311:1632-40
   PubMed Web of Science ®Google Scholar
• Kleindorfer D, Lindsell CJ, Brass L, et al. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008;39:924-8
   PubMed Web of Science ®Google Scholar
• Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20
   PubMed Web of Science ®Google Scholar
• Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 2015;372:528-36
   PubMed Web of Science ®Google Scholar
• Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009-18
   PubMed Web of Science ®Google Scholar
• Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019-30
   PubMed Web of Science ®Google Scholar
• Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296-306
   PubMed Web of Science ®Google Scholar
• Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. Jama 1998;279:1288-92
   PubMed Web of Science ®Google Scholar
• Kleindorfer D, Miller R, Sailor-Smith S, et al. The challenges of community-based research: the beauty shop stroke education project. Stroke 2008;39:2331-5
   PubMed Web of Science ®Google Scholar
• Reeves MJ, Arora S, Broderick JP, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute. Stroke 2005;36:1232-40
   PubMed Web of Science ®Google Scholar
• Lichtman JH, Watanabe E, Allen NB, et al. Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke 2009;40:3845-50
   PubMed Web of Science ®Google Scholar
• Fassbender K, Walter S, Liu Y, et al. “Mobile stroke unit” for hyperacute stroke treatment. Stroke 2003;34:e44
   PubMed Web of Science ®Google Scholar
• Walter S, Kostpopoulos P, Haass A, et al. Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS One 2010;5:e13758
   PubMed Web of Science ®Google Scholar
• Ebinger M, Winter B, Wendt M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. Jama 2014;311:1622-31
   PubMed Web of Science ®Google Scholar
• Kostopoulos P, Walter S, Haass A, et al. Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology 2012;78:1849-52
   PubMed Web of Science ®Google Scholar
• Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. Jama 2015;313:824-36
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Starkman S, Eckstein M, et al. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000;31:71-6
   PubMed Web of Science ®Google Scholar
• Llanes JN, Kidwell CS, Starkman S, et al. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care 2004;8:46-50
   PubMedGoogle Scholar
• Kothari RU, Pancioli A, Liu T, et al. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999;33:373-8
   PubMed Web of Science ®Google Scholar
• Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71-6
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Ali SF, Reeves MJ, et al. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes 2013;6:543-9
   PubMed Web of Science ®Google Scholar
• Donnan GA, Davis SM. Neurologist, internist, or strokologist? Stroke 2003;34:2765
   PubMed Web of Science ®Google Scholar
• Demaerschalk BM, Bobrow BJ, Raman R, et al. CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist. Stroke 2012;43:3095-7
   PubMed Web of Science ®Google Scholar
• Hess DC, Audebert HJ. The history and future of telestroke. Nature Rev Neurol 2013;9:340-50
   PubMed Web of Science ®Google Scholar
• Levine SR, Gorman M. “Telestroke”: the application of telemedicine for stroke. Stroke 1999;30:464-9
   PubMed Web of Science ®Google Scholar
• Audebert HJ, Kukla C, Clarmann von Claranau S, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005;36:287-91
   PubMed Web of Science ®Google Scholar
• Hess DC, Wang S, Hamilton W, et al. REACH: clinical feasibility of a rural telestroke network. Stroke 2005;36:2018-20
   PubMed Web of Science ®Google Scholar
• LaMonte MP, Xiao Y, Hu PF, et al. Shortening time to stroke treatment using ambulance telemedicine: TeleBAT. J Stroke Cardiovasc Dis 2004;13:148-54
   PubMedGoogle Scholar
• Meyer BC, Lyden PD, Al-Khoury L, et al. Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology 2005;64:1058-60
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Rosenthal ES, Hirshberg A, et al. Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med 2004;11:1193-7
   PubMed Web of Science ®Google Scholar
• Shafqat S, Kvedar JC, Guanci MM, et al. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke 1999;30:2141-5
   PubMed Web of Science ®Google Scholar
• Wang S, Lee SB, Pardue C, et al. Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke 2003;34:e188-91
   PubMed Web of Science ®Google Scholar
• Handschu R, Littmann R, Reulbach U, et al. Telemedicine in emergency evaluation of acute stroke: interrater agreement in remote video examination with a novel multimedia system. Stroke 2003;34:2842-6
   PubMed Web of Science ®Google Scholar
• Audebert HJ, Schenkel J, Heuschmann PU, et al. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Germany. Lancet Neurol 2006;5:742-8
   PubMed Web of Science ®Google Scholar
• Schwab S, Vatankhah B, Kukla C, et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007;69:898-903
   PubMed Web of Science ®Google Scholar
• Audebert HJ, Schultes K, Tietz V, et al. Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS). Stroke 2009;40:902-8
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2009;40:2616-34
   PubMed Web of Science ®Google Scholar
• Muller-Barna P, Schwamm LH, Haberl RL. Telestroke increases use of acute stroke therapy. Curr Opin Neurol 2012;25:5-10
   PubMed Web of Science ®Google Scholar
• Silva GS, Farrell S, Shandra E, et al. The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke 2012;43:2078-85
   PubMed Web of Science ®Google Scholar
• Switzer JA, Demaerschalk BM, Xie J, et al. Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals’ perspectives. Circ Cardiovasc Qual Outcomes 2013;6:18-26
   PubMed Web of Science ®Google Scholar
• Wechsler LR, Tsao JW, Levine SR, et al. Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology 2013;80:670-6
   PubMed Web of Science ®Google Scholar
• Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials. Telemed J E Health 2012;18:230-7
   PubMed Web of Science ®Google Scholar
• Puetz V, Bodechtel U, Gerber JC, et al. Reliability of brain CT evaluation by stroke neurologists in telemedicine. Neurology 2013;80:332-8
   PubMed Web of Science ®Google Scholar
• Sairanen T, Soinila S, Nikkanen M, et al. Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology 2011;76:1145-52
   PubMed Web of Science ®Google Scholar
• Choi JY, Porche NA, Albright KC, et al. Using telemedicine to facilitate thrombolytic therapy for patients with acute stroke. Jt Comm J Qual Patient Saf 2006;32:199-205
   PubMedGoogle Scholar
• Meyer BC, Raman R, Ernstrom K, et al. Assessment of long-term outcomes for the STRokE DOC telemedicine trial. J Stroke Cardiovasc Dis 2012;21:259-64
   PubMed Web of Science ®Google Scholar
• Meyer BC, Raman R, Hemmen T, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008;7:787-95
   PubMed Web of Science ®Google Scholar
• Wu TC, Nguyen C, Ankrom C, et al. Prehospital utility of rapid stroke evaluation using in-ambulance telemedicine: a pilot feasibility study. Stroke 2014;45:2342-7
   PubMed Web of Science ®Google Scholar
• Bergrath S, Reich A, Rossaint R, et al. Feasibility of prehospital teleconsultation in acute stroke–a pilot study in clinical routine. PLoS One 2012;7:e36796
   PubMed Web of Science ®Google Scholar
• Van Hooff RJ, Cambron M, Van Dyck R, et al. Prehospital unassisted assessment of stroke severity using telemedicine: a feasibility study. Stroke 2013;44:2907-9
   PubMed Web of Science ®Google Scholar
• Van Hooff RJ, De Smedt A, De Raedt S, et al. Unassisted assessment of stroke severity using telemedicine. Stroke 2013;44:1249-55
   PubMed Web of Science ®Google Scholar
• Gonzalez MA, Hanna N, Rodrigo ME, et al. Reliability of prehospital real-time cellular video phone in assessing the simplified National Institutes Of Health Stroke Scale in patients with acute stroke: a novel telemedicine technology. Stroke 2011;42:1522-7
   PubMed Web of Science ®Google Scholar
• Johnston KC, Worrall BB. Teleradiology Assessment of Computerized Tomographs Online Reliability Study (TRACTORS) for acute stroke evaluation. Tele Med J E Health 2003;9:227-33
   PubMed Web of Science ®Google Scholar
• Spokoyny I, Raman R, Ernstrom K, et al. Pooled assessment of computed tomography interpretation by vascular neurologists in the STRokE DOC telestroke network. J Stroke Cardiovasc Dis 2014;23:511-15
   PubMed Web of Science ®Google Scholar
• De Luca G, Suryapranata H, Zijlstra F, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991-7
   PubMed Web of Science ®Google Scholar
• O’Connor RE, Brady W, Brooks SC, et al. Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122:S787-817
   PubMed Web of Science ®Google Scholar
• Ting HH, Krumholz HM, Bradley EH, et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation 2008;118:1066-79
   PubMed Web of Science ®Google Scholar
• Zegre Hemsey JK, Dracup K, Fleischmann KE, et al. Prehospital electrocardiographic manifestations of acute myocardial ischemia independently predict adverse hospital outcomes. J Emerg Med 2013;44:955-61
   PubMed Web of Science ®Google Scholar
• Ravn-Fischer A, Karlsson T, Johanson P, Herlitz J. Prehospital ECG signs of acute coronary occlusion are associated with reduced one-year mortality. Int J Cardiol 2013;168:3594-8
   PubMed Web of Science ®Google Scholar
• Ebinger M, Lindenlaub S, Kunz A, et al. Prehospital thrombolysis: a manual from Berlin. J Vis Exp 2013;e50534
   Google Scholar
• Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol 2015;72:25-30
   PubMed Web of Science ®Google Scholar
• Ebinger M, Rozanski M, Waldschmidt C, et al. PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients - study. Int J Stroke 2012;7:348-53
   PubMed Web of Science ®Google Scholar
• Wendt M, Ebinger M, Kunz A, et al. Improved prehospital triage of patients with stroke in a specialized stroke ambulance: results of the pre-hospital acute neurological therapy and optimization of medical care in stroke study. Stroke 2015;46:740-5
   PubMed Web of Science ®Google Scholar
• BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit (BEST-MSU). [Last Accessed 15 June, 2015]
   Google Scholar
• Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke. Curr Treat Options Neurol 2003;5:367-75
   PubMedGoogle Scholar
• Donnan GA. The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke 2008;39:242
   PubMed Web of Science ®Google Scholar
• Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009;40:S111-14
   PubMed Web of Science ®Google Scholar
• Saver JL. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke. Pharmacotherapy 2010;30:62s-9
   PubMed Web of Science ®Google Scholar
• Saver JL. Improving reperfusion therapy for acute ischaemic stroke. J Thromb Haemost 2011;9(Suppl 1):333-43
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Liebeskind DS, Starkman S, Saver JL. Trends in acute ischemic stroke trials through the 20th century. Stroke 2001;32:1349-59
   PubMed Web of Science ®Google Scholar
• Ferguson KN, Kidwell CS, Starkman S, Saver JL. Hyperacute treatment initiation in neuroprotective agent stroke trials. J Stroke Cardiovasc Dis 2004;13:109-12
   PubMedGoogle Scholar
• Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-7
   PubMed Web of Science ®Google Scholar
• Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63
   PubMed Web of Science ®Google Scholar
• Chang JJ, Sanossian N. Pre-Hospital Glyceryl Trinitrate: Potential for Use in Intracerebral Hemorrhage. J Neurol Disord 2013;2
   Google Scholar
• Muir KW. Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. CNS drugs 2001;15:921-30
   PubMed Web of Science ®Google Scholar
• Kornau HC, Schenker LT, Kennedy MB, Seeburg PH. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science (New York, NY) 1995;269:1737-40
   Web of Science ®Google Scholar
• Cui H, Hayashi A, Sun HS, et al. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci 2007;27:9901-15
   PubMed Web of Science ®Google Scholar
• Aarts M, Liu Y, Liu L, et al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science (New York, NY) 2002;298:846-50
   Web of Science ®Google Scholar
• Cook DJ, Teves L, Tymianski M. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 2012;483:213-17
   PubMed Web of Science ®Google Scholar
• Hill MD, Martin RH, Mikulis D, et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2012;11:942-50
   PubMed Web of Science ®Google Scholar
• Field Randomization of NA-1 Therapy in Early Responders (FRONTIER)
   Google Scholar
• Dirks M, Zonneveld TP, Dippel DW, et al. Elevated pretreatment blood pressure and IV thrombolysis in stroke. Neurology 2015;84:1419-25
   PubMed Web of Science ®Google Scholar
• Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175-81
   PubMed Web of Science ®Google Scholar
• Kazui S, Naritomi H, Yamamoto H, et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996;27:1783-7
   PubMed Web of Science ®Google Scholar
• Sanossian NSS HS, Eckstein M, Stratton S, et al. Early Clinical Deterioration of Stroke Patients Assessed in the Field within Two Hours of Symptom Onset. Stroke 2011;42:e291
   PubMed Web of Science ®Google Scholar
• Willmot MR, Bath PM. The potential of nitric oxide therapeutics in stroke. Expert Opin Investig Drugs 2003;12:455-70
   PubMed Web of Science ®Google Scholar
• Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993;364:626-32
   PubMed Web of Science ®Google Scholar
• Pluta RM, Rak R, Wink DA, et al. Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery 2001;48:884-92. discussion 92-3
   PubMed Web of Science ®Google Scholar
• Willmot M, Ghadami A, Whysall B, et al. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006;47:1209-15
   PubMed Web of Science ®Google Scholar
• Moppett IK, Sherman RW, Wild MJ, et al. Effects of norepinephrine and glyceryl trinitrate on cerebral haemodynamics: transcranial Doppler study in healthy volunteers. Br J Anaesth 2008;100:240-4
   PubMed Web of Science ®Google Scholar
• Bath PM, Woodhouse L, Scutt P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015;385:617-28
   PubMed Web of Science ®Google Scholar
• Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke 2013;44:3120-8
   PubMed Web of Science ®Google Scholar
• Shaw L, Price C, McLure S, et al. Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): results from the pilot randomised controlled trial. Emerg Med J 2014;31:994-9
   PubMed Web of Science ®Google Scholar
• Walsh SR, Nouraei SA, Tang TY, et al. Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vasc Endovascular Surg 2010;44:434-9
   PubMed Web of Science ®Google Scholar
• Hougaard KD, Hjort N, Zeidler D, et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke 2014;45:159-67
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-7
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Alexandrov AV. Reperfusion therapies of acute ischemic stroke: potentials and failures. Front Neurol 2014;5:215
   PubMed Web of Science ®Google Scholar
• Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-8
   PubMed Web of Science ®Google Scholar
• Alexandrov AV. Ultrasound identification and lysis of clots. Stroke 2004;35:2722-5
   PubMed Web of Science ®Google Scholar
• Goldstein P, Wiel E. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours). Minerva Anestesiol 2005;71:297-302
   PubMedGoogle Scholar
• Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 2005;36:2311-20
   PubMed Web of Science ®Google Scholar
• Jang IK, Brown DF, Giugliano RP, et al. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study. J Am Coll Cardiol 1999;33:1879-85
   PubMed Web of Science ®Google Scholar
• Barreto AD, Alexandrov AV, Lyden P, et al. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke 2012;43:770-5
   PubMed Web of Science ®Google Scholar
• Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke (ARTSS-2)
   Google Scholar
• Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 1997;95:846-54
   PubMed Web of Science ®Google Scholar
• Pancioli AM, Adeoye O, Schmit PA, et al. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke 2013;44:2381-7
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Eggers J, Ribo M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 2010;41:280-7
   PubMed Web of Science ®Google Scholar
• Daffertshofer M, Gass A, Ringleb P, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005;36:1441-6
   PubMed Web of Science ®Google Scholar
• Molina CA, Ribo M, Rubiera M, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006;37:425-9
   PubMed Web of Science ®Google Scholar
• CLOTBUST Hands-Free (CLOTBUST-HF)
   Google Scholar
• Barlinn K, Barreto AD, Sisson A, et al. CLOTBUST-hands free: initial safety testing of a novel operator-independent ultrasound device in stroke-free volunteers. Stroke 2013;44:1641-6
   PubMed Web of Science ®Google Scholar
• Rajan S, Baraniuk S, Parker S, et al. Implementing a mobile stroke unit program in the United States: why, how, and how much? JAMA Neurol 2015;72:229-34
   PubMed Web of Science ®Google Scholar
• Grotta JC. tPA for stroke: important progress in achieving faster treatment. Jama 2014;311:1615-17
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 2014;129:399-410
   PubMed Web of Science ®Google Scholar
• Taylor TN, Davis PH, Torner JC, et al. Lifetime cost of stroke in the United States. Stroke 1996;27:1459-66
   PubMed Web of Science ®Google Scholar